id
int64 15.9k
8,788B
| url
stringlengths 31
668
| text
stringlengths 11
990
| width
int32 200
9k
| height
int32 200
7.56k
| image_phash
stringlengths 16
16
| text_length
int32 11
990
| word_count
int32 3
180
| num_tokens_bert
int32 3
369
| num_tokens_gpt
int32 3
341
| num_faces
int32 0
240
| clip_similarity_vitb32
float32 0.07
0.47
| clip_similarity_vitl14
float32 -0.01
0.5
| nsfw_score_opennsfw2
float32 0
0.5
| nsfw_score_gantman
float32 0
0.5
| watermark_score
float32 0
1
| aesthetic_score_laion_v2
float32 2.19
6.63
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6,150,393,183,135 | Accelerate Gene Therapy Production with New AAV-Based Technology | 640 | 360 | bdc4c01bcf64532e | 64 | 9 | 11 | 13 | 0 | 0.236694 | 0.200195 | 0.000122 | 0.015383 | 0.050999 | 5.00865 |
|
5,858,335,761,501 | SUMMARY OF THE 13th INTERNATIONAL SYMPOSIUM ON STEM CELL THERAPY AND CARDIOVASCULAR INNOVATIONS (Mad | 366 | 275 | e389436abcd4f80d | 100 | 14 | 15 | 35 | 14 | 0.281982 | 0.236938 | 0.000207 | 0.010098 | 0.001766 | 5.294316 |
|
3,178,275,909,312 | What Is Allogeneic Stem Cell Transplantation Patients Clinimacs Cd34 Reagent System Fda Approved Cell Therapy Products Miltenyi Biotec Norge | 2,500 | 2,474 | e2916e9d426bd06e | 140 | 19 | 33 | 36 | 0 | 0.257568 | 0.112183 | 0.006104 | 0.019806 | 0.256948 | 5.320401 |
|
841,813,978,017 | Managing Patients Treated With CAR T-Cell Therapy | 540 | 340 | c863765c9f2762d0 | 49 | 8 | 9 | 11 | 0 | 0.262695 | 0.244995 | 0.002439 | 0.029303 | 0.194442 | 5.347005 |
|
1,752,347,086,218 | Sponsors of in vivo Gene Therapy clinical trials, per year | 575 | 500 | eb81bd2fa41b19c4 | 58 | 10 | 11 | 12 | 0 | 0.358398 | 0.347168 | 0.002111 | 0.017754 | 0.00068 | 5.396817 |
|
3,032,247,067,457 | Ocrevus Targets Certain T-Cells, Along with B-Cells, in MS Patients, Study Reports | 1,000 | 480 | d50b5bd104f1e665 | 82 | 14 | 21 | 25 | 0 | 0.283936 | 0.181396 | 0.016586 | 0.043114 | 0.351254 | 5.105426 |
|
3,393,024,317,246 | Parkinson’s Disease Cell Therapy Relieves Symptoms in Monkeys | 800 | 400 | a9ceba854582d5ab | 61 | 9 | 11 | 14 | 0 | 0.27832 | 0.246338 | 0.002031 | 0.003795 | 0.049107 | 4.37108 |
|
3,410,204,375,463 | Japan Approves iPS Cell Therapy Trial for Spinal Cord Injury | 400 | 280 | c423fcc0e1733ce3 | 60 | 10 | 12 | 13 | 0 | 0.282471 | 0.220093 | 0.064941 | 0.151322 | 0.43422 | 4.854835 |
|
1,400,159,454,705 | Bellevue vet now offering stem-cell therapy for four-legged friends | 1,302 | 868 | e8bdd42007c8cf97 | 67 | 11 | 13 | 15 | 2 | 0.276855 | 0.229736 | 0.000522 | 0.02715 | 0.000094 | 5.097359 |
|
3,745,211,988,125 | A Review of the Study: Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and Umbilical Cord Blood as Sources of Cell Therapy Oklahoma City, OKC | 300 | 200 | ce221349b5e9b69a | 180 | 29 | 40 | 45 | 0 | 0.248047 | 0.20813 | 0.026077 | 0.011993 | 0.247016 | 5.174964 |
|
704,375,403,464 | Stem Cell Therapy for COPD | 400 | 250 | 849357ce59c538e5 | 26 | 5 | 6 | 7 | 0 | 0.317383 | 0.255615 | 0.044464 | 0.01583 | 0.606746 | 4.813145 |
|
2,405,182,478,864 | Schematic representation of the retina and pattern of expression of retinal genes. Genes for which gene therapy approaches are in clinical testing are indicated in bold. RPE: retinal pigment epithelium. | 1,140 | 652 | f81f05c0eabffc00 | 202 | 30 | 45 | 41 | 0 | 0.306641 | 0.293701 | 0.001893 | 0.004424 | 0.115634 | 4.144158 |
|
6,193,343,072,463 | Dyno, Roche Ink Gene Therapy Deal Worth up to $1.8B | 740 | 400 | bcbc04c303f49eda | 51 | 11 | 17 | 17 | 0 | 0.349365 | 0.281006 | 0.00668 | 0.025421 | 0.002499 | 4.961923 |
|
5,823,975,922,416 | Opened drug capsule medicine business concept. DNA gene therapy blue medicament prebiotic probiotic ball health care cure illness. Antibiotic vitamin medical nutrition low poly vector illustration | 600 | 360 | 95e96a667297092d | 196 | 26 | 33 | 35 | 0 | 0.232666 | 0.248779 | 0.007477 | 0.007664 | 0.604955 | 5.030252 |
|
635,655,845,353 | T-Cell Immunotherapy for Cancer Pipeline Market Analysis Report | 220 | 285 | ebf141e3607160d7 | 63 | 9 | 14 | 11 | 0 | 0.336426 | 0.311768 | 0.086182 | 0.033262 | 0.021325 | 4.134272 |
|
3,994,320,333,681 | Amos Gilhar: Non-conventional T-cells in the Pathogenesis of AA • NKG2D expressed also on ILCs • humanized mouse AA model ... | 638 | 359 | da2fa56a5a9195c2 | 125 | 20 | 35 | 40 | 1 | 0.253418 | 0.238037 | 0.000818 | 0.030184 | 0.366028 | 3.716856 |
|
7,164,005,983,586 | Weizmann Institute-Born Cell Therapy Technology In Clinical Trials for ALS Patients | 640 | 444 | fa438d2d68d73164 | 83 | 12 | 15 | 15 | 0 | 0.275146 | 0.235107 | 0.000143 | 0.016648 | 0.447121 | 5.212375 |
|
335,008,008,579 | 3-Viral oncogenes Some of DNA and RNA viruses have been linked with human cancer. E.g. 1-Human T-cell leukemia virus type 1 (HTLV-1): | 960 | 720 | d141ae19e93636bc | 133 | 27 | 42 | 41 | 0 | 0.341064 | 0.338135 | 0.004238 | 0.004485 | 0.033044 | 4.715118 |
|
4,741,644,410,713 | SARS-CoV-2 variation in the immunodominant Wuhan-YLQPRTFLL dominant HLA A*02:01- restricted CD8 T-cell epitope. a, Cumulative frequency of all sequences; sequences in the B.1.177 lineage; and sequences possessing the P272L variant, both in B.1.177 and other lineages across the United Kingdom (left) and worldwide (right). Total number of P272L variants by nation, binned into periods of 10 epidemiological (EPI) weeks is shown in Supplementary Figure 1. b, Top 15 most frequently observed variants observed in worldwide Spike glycoprotein sequence data in lineage B.1.177. Data for all lineages is shown in Supplementary Figure 3. c, Phylogenetic tree showing 1227 taxa with variants at Spike position 272, with colours indicating subtrees representing potential independent mutations, computed by ASR on a larger tree of 200 221 taxa (not shown). d, Total number of sequences possessing P272L variant in England and Wales per administrative region up to and including 31st January 2021. | 959 | 748 | cb35b5caa4d2934a | 988 | 159 | 237 | 232 | 0 | 0.246704 | 0.201294 | 0.007942 | 0.048841 | 0.000008 | 4.784273 |
|
6,502,580,891,638 | lab frontpage CAR-T cell overview direct | 456 | 374 | f73444497a2e346b | 40 | 7 | 9 | 9 | 0 | 0.327393 | 0.311523 | 0.00038 | 0.018356 | 0.066604 | 4.579611 |
|
8,134,668,398,964 | MTHFR Gene Therapy Demystified: Crack Your Genetic Code to Better Health by [Dr. Robin Terranella | 228 | 346 | 9441782f4ef587d8 | 97 | 15 | 24 | 24 | 0 | 0.36792 | 0.386719 | 0.002071 | 0.021836 | 0.012736 | 3.894844 |
|
6,828,998,573,633 | Tiny nano-device for gene therapy | 640 | 482 | ae859b9836c44db9 | 33 | 6 | 7 | 8 | 0 | 0.304688 | 0.283691 | 0.008171 | 0.03541 | 0.004131 | 4.904561 |
|
3,281,355,469,870 | Novel gene therapy works to reverse heart failure | 300 | 400 | de483cf26b9b8c14 | 49 | 8 | 8 | 9 | 0 | 0.288574 | 0.269287 | 0.000583 | 0.032989 | 0.073669 | 4.634231 |
|
6,442,450,966,072 | How far can gene therapy go? FDA announces another gene therapy milestone with Luxturna approval featured image | 640 | 360 | b37333332626cc99 | 111 | 17 | 20 | 21 | 0 | 0.291992 | 0.251465 | 0.000995 | 0.022258 | 0.141059 | 3.626143 |
|
6,004,364,701,258 | dissertation interview script and essay on gene therapy | 791 | 1,024 | af72d2d7c0cd180d | 55 | 8 | 8 | 10 | 0 | 0.206055 | 0.121155 | 0.000157 | 0.043709 | 0.016794 | 4.195587 |
|
1,709,397,244,610 | EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response | 640 | 360 | 8a9772b291b266ec | 67 | 12 | 19 | 23 | 0 | 0.274658 | 0.214111 | 0.000157 | 0.021073 | 0.605067 | 5.120363 |
|
5,514,738,391,354 | ID-KD vaccine induced T-cell cytotoxicity | 700 | 561 | 9f06f02bf0e82db8 | 41 | 7 | 14 | 12 | 0 | 0.324707 | 0.272705 | 0.00462 | 0.008695 | 0.852862 | 4.54762 |
|
850,404,302,932 | Gene therapy may hold key to treating life-threatening Danon disease | 696 | 392 | c41bf724e78c5aa1 | 68 | 11 | 13 | 13 | 0 | 0.297607 | 0.259521 | 0.001589 | 0.013192 | 0.499164 | 5.387753 |
|
2,886,218,159,526 | Validation of a Novel Portable Freezing Device in the Optimal Freezing of Peripheral Blood Mononuclear Cells for Potential Cell Therapy Use | 400 | 555 | 88fbb4c47b807aca | 139 | 21 | 24 | 29 | 0 | 0.26709 | 0.253662 | 0.000374 | 0.011893 | 0.006009 | 4.60921 |
|
5,987,184,918,109 | OrganaBio Begins Construction on its cGMP Cell and Gene Therapy Manufacturing Facility | 378 | 250 | bba3460f9f5858a1 | 86 | 12 | 16 | 16 | 0 | 0.268799 | 0.252686 | 0 | 0.107388 | 0.000721 | 5.437741 |
|
8,237,747,345,851 | Cell therapy innovation set to reverse impacts of ageing | 269 | 539 | b147461cc1d9bfe0 | 56 | 9 | 10 | 9 | 0 | 0.208862 | 0.202271 | 0.024536 | 0.027816 | 0.012396 | 5.142381 |
|
6,098,854,253,330 | ADULT STEM CELL THERAPY | 320 | 414 | bf71616161616367 | 23 | 4 | 4 | 9 | 0 | 0.230713 | 0.253174 | 0.015175 | 0.048374 | 0.191434 | 4.289055 |
|
2,010,045,159,507 | THYMUS & SPLEEN The thymus produces T-cells that fight infections, it is located just above the heart. | 960 | 720 | ab71f07cd5842b0b | 102 | 17 | 24 | 28 | 0 | 0.385742 | 0.338379 | 0.005695 | 0.015369 | 0.026302 | 3.666745 |
|
4,544,075,930,392 | colorectal cancer gene therapy | 1,442 | 839 | bc3bc3c46d4f3031 | 30 | 4 | 6 | 7 | 0 | 0.284668 | 0.240234 | 0.003643 | 0.019784 | 0.432593 | 4.496639 |
|
7,103,876,138,481 | Cell therapy for ageing | 749 | 562 | ff69d59441c15519 | 23 | 4 | 5 | 4 | 1 | 0.26416 | 0.24585 | 0.009613 | 0.003608 | 0.004902 | 4.830368 |
|
2,757,369,768,900 | physical therapy after stem cell therapy | 960 | 540 | bcc92f3087cc9393 | 40 | 6 | 6 | 6 | 1 | 0.40332 | 0.308594 | 0.016617 | 0.01557 | 0.042302 | 4.942157 |
|
4,166,118,772,145 | Process of Stem Cell Therapy | 582 | 300 | dba6a6a4a7a4a6a4 | 28 | 5 | 5 | 7 | 0 | 0.28125 | 0.210083 | 0.002062 | 0.005586 | 0.080951 | 4.287614 |
|
1,357,210,271,529 | https://img.in-part.com/resize?url=https://s3-eu-west-1.amazonaws.com/assets.in-part.com/technologies/header-images/ZfgnkU9KQzG7KRmee0rE_JawaharSwaminathanCC0.jpg&stripmeta=true&noprofile=true&width=1200&height=820 | TRAIL Fusion Protein: Novel Gene Therapy for Oncology | 800 | 600 | e9c796382cc76338 | 53 | 8 | 10 | 13 | 0 | 0.26123 | 0.227783 | 0.01519 | 0.02621 | 0.634127 | 4.89237 |
2,637,110,255,572 | Genetic engineering research concept of human biotech modification and gene therapy. | 400 | 400 | d6525a7c52432b9d | 84 | 11 | 13 | 13 | 1 | 0.313477 | 0.273438 | 0.012733 | 0.031541 | 0.21015 | 4.759215 |
|
1,992,864,870,362 | Transportation Solutions for Cell and Gene Therapy | 720 | 405 | aae84c9414d33b6f | 50 | 7 | 7 | 8 | 0 | 0.324951 | 0.346436 | 0.03479 | 0.008873 | 0.034461 | 5.092329 |
|
6,279,242,820,987 | LYMPH NODES and LYMPHOCYTES Lymph nodes contain lymphocytes Killer T-Cells- surround and destroy pathogens B-Cells- produce antibodies that attack pathogens White blood cells multiply when infections are in your body, the lymph nodes then fill with WBCs (white blood cells)- this is why your lymph nodes are swollen when you are sick. | 960 | 720 | abe53e6ad14ac1d0 | 334 | 54 | 81 | 79 | 0 | 0.360352 | 0.291748 | 0.001619 | 0.015917 | 0.023757 | 3.679103 |
|
2,602,750,589,738 | Idiopathic Encephalopathy Treatment with Stem Cell Therapy | 1,920 | 746 | c886455218f5efd6 | 58 | 7 | 13 | 14 | 1 | 0.342285 | 0.324219 | 0.006783 | 0.192422 | 0.606717 | 4.503778 |
|
4,243,427,763,560 | $1M Gene Therapy Research Grant Launched by PPMD, Duchenne UK | 1,000 | 480 | f4e84f1b439e4495 | 61 | 10 | 16 | 18 | 0 | 0.233398 | 0.199829 | 0.023712 | 0.016684 | 0.402292 | 5.775355 |
|
2,576,980,858,589 | read Cell Therapy for Brain Injury | 1,500 | 834 | 91f0274f6ca76263 | 34 | 6 | 6 | 6 | 0 | 0.174316 | 0.10675 | 0.084412 | 0.013296 | 0.004166 | 5.594903 |
|
7,533,373,068,861 | Coronavirus Patient Saved By Stem Cell Therapy | Cells4Life | 1,080 | 675 | 99a3941c4c5afbb1 | 59 | 8 | 12 | 16 | 0 | 0.279541 | 0.234253 | 0.033936 | 0.046962 | 0.185009 | 5.407615 |
|
3,487,513,801,536 | Stem cell therapy in Critical Limb Ischemia | 700 | 394 | a0c34b8dd9bd6632 | 43 | 7 | 9 | 11 | 2 | 0.242188 | 0.23291 | 0.000535 | 0.004311 | 0.959059 | 4.329615 |
|
1,245,541,040,781 | https://i1.abocdn.com/productimage/v777ecad0/x3y38o3m6x4b/?w=300&h=200 | Image no. 3 for anti-IL2-Inducible T-Cell Kinase (ITK) antibody (ABIN1109424 | 300 | 200 | bacc6399cc33cc32 | 76 | 13 | 29 | 29 | 0 | 0.253174 | 0.258057 | 0.00927 | 0.013116 | 0.000211 | 3.924892 |
4,827,543,958,953 | buy interdisciplinary approaches to gene therapy legal ethical and scientific aspects | 1,200 | 1,149 | e5c71b301ba152fc | 85 | 11 | 11 | 12 | 1 | 0.199585 | 0.105774 | 0.05307 | 0.051986 | 0.173451 | 4.258997 |
|
3,264,175,302,101 | Emerging Trends in Cell and Gene Therapy | 1,200 | 967 | d9cb35644fda3031 | 40 | 7 | 7 | 8 | 2 | 0.144897 | 0.134277 | 0.000511 | 0.011265 | 0.000378 | 5.402154 |
|
3,427,384,400,991 | Gene Therapy for Vision Loss | 500 | 250 | d66ec1393132cc73 | 28 | 5 | 5 | 5 | 1 | 0.292969 | 0.234741 | 0.015884 | 0.304402 | 0.313733 | 5.450529 |
|
5,497,558,409,149 | Cardiac stem cell therapy | 1,920 | 2,822 | fbb4b052831a95e5 | 25 | 4 | 4 | 5 | 1 | 0.29541 | 0.244629 | 0.009781 | 0.048506 | 0.996146 | 4.947488 |
|
2,327,872,475,548 | gene therapy restores function after heart attack | 350 | 220 | d81037efd80d2f19 | 49 | 7 | 8 | 8 | 0 | 0.346436 | 0.280273 | 0.011398 | 0.016797 | 0.88452 | 5.271186 |
|
5,025,112,495,568 | Ana on Twitter: "This T-cell transformed into a CAR-T cell is now ready for action! # | 474 | 262 | ea29b53e4aca8794 | 90 | 18 | 26 | 27 | 0 | 0.330078 | 0.331543 | 0.00441 | 0.015164 | 0.110988 | 3.907986 |
|
5,480,378,629,214 | terapia : Abstract particles with trails. 4K UHD animation. Gene therapy theme. | 450 | 252 | c30f1ee03371e11f | 79 | 11 | 19 | 19 | 0 | 0.307617 | 0.244751 | 0.016769 | 0.233975 | 0.519859 | 5.01084 |
|
284,779 | Mesoblast stem cell therapy | 640 | 360 | 82c038dbf185cf1f | 27 | 4 | 7 | 7 | 0 | 0.190308 | 0.121826 | 0.000202 | 0.004976 | 0.218559 | 4.269614 |
|
6,940,667,219,092 | Parkinson’s Disease Cell Therapy Relieves Symptoms in Monkeys | 220 | 220 | fbc0a4d94aa4dab2 | 61 | 9 | 11 | 14 | 0 | 0.275391 | 0.234131 | 0.0271 | 0.004906 | 0.013044 | 4.454696 |
|
386,547,236,569 | Experts discuss the CAR-T cell therapy space | 1,600 | 800 | ee2c9a31c69a9ae2 | 44 | 8 | 9 | 9 | 2 | 0.294189 | 0.25708 | 0.004925 | 0.039874 | 0.116438 | 4.484177 |
|
4,690,104,876,893 | Anti-CD30 CAR T-cell therapy appears safe, effective in advanced Hodgkin lymphoma | 200 | 200 | 82dcd00f9ce7c71a | 81 | 13 | 23 | 19 | 0 | 0.265137 | 0.219482 | 0.000856 | 0.020032 | 0.000047 | 3.766307 |
|
5,995,774,666,456 | Biogen plans trial of Spinraza in patients not responding to SMA gene therapy | 605 | 340 | cd223b4716d35a36 | 77 | 13 | 17 | 17 | 0 | 0.257568 | 0.199585 | 0.000196 | 0.015809 | 0.013158 | 4.888351 |
|
3,453,153,770,598 | https://i1.abocdn.com/productimage/v087b4cae/z7j69a0r7d7j/?w=300&h=200 | Image no. 1 for anti-T-Cell Acute Lymphocytic Leukemia 2 (TAL2) (N-Term) antibody (ABIN6740552 | 300 | 200 | e6cccc33cc6698cc | 94 | 16 | 36 | 36 | 0 | 0.297607 | 0.260498 | 0.003952 | 0.013969 | 0.02399 | 4.36503 |
3,186,865,791,435 | trails : Abstract particles with trails. 4K UHD animation. Gene therapy theme. | 450 | 252 | c30f1ee03371e11f | 78 | 11 | 17 | 18 | 0 | 0.304199 | 0.224487 | 0.016769 | 0.233975 | 0.519859 | 5.01084 |
|
1,812,476,341,932 | download gene therapy for | 500 | 500 | 9f79d0c46593668c | 25 | 4 | 4 | 4 | 0 | 0.187622 | 0.131104 | 0.00285 | 0.045529 | 0.282453 | 5.260502 |
|
2,559,800,544,365 | Neal Flomenberg Thomas Jefferson University Sidney Kimmel Cancer Center Bone Marrow Transplant Cell Therapy Expert | 628 | 650 | d8251be6834eb89e | 114 | 15 | 18 | 19 | 1 | 0.262939 | 0.214966 | 0.001177 | 0.014538 | 0.012456 | 5.53464 |
|
1,975,685,134,392 | http://sfbayview.com/wp-content/uploads/2015/01/Pelican-Bay-Prison-Guard-George-Sherman-carries-rifle-when-guard-enters-8-cell-pod-by-John-Burgess-Santa-Rosa-Press-Dem-300x202.jpg | Pacing his SHU control booth, Pelican Bay Prison Guard George Sherman picks up his rifle whenever a guard enters the eight-cell pod. – Photo: John Burgess, Santa Rosa Press Democrat | 300 | 202 | 94654b6b1ff086d2 | 181 | 30 | 38 | 40 | 0 | 0.283203 | 0.279297 | 0.05661 | 0.45481 | 0.000476 | 5.260694 |
6,373,731,866,125 | Why does CAR-T cancer therapy give this Stanford oncologist hope? Watch this video | 520 | 260 | bc2ec3a02e66f193 | 82 | 14 | 18 | 18 | 1 | 0.308594 | 0.254883 | 0.002726 | 0.067544 | 0.034381 | 4.675405 |
|
2,534,031,100,926 | Q&A] Taking the Temperature of Cell Therapy Logistics | 649 | 365 | fd326605262c61df | 53 | 9 | 11 | 13 | 1 | 0.305908 | 0.340332 | 0.018921 | 0.008619 | 0.304456 | 4.724316 |
|
429,497,437,789 | http://med.stanford.edu/news/all-news/2017/07/rothschild-gift-establishes-stanford-center-for-cancer-cell-therapy/_jcr_content/image.img.620.high.jpg/rothschild-group.jpg | Jeffrey and Marieke Rothschild gift establishes Stanford Center for Cancer Cell Therapy | 620 | 348 | ceb1b9c453c423ce | 87 | 12 | 13 | 14 | 4 | 0.277588 | 0.219604 | 0.006424 | 0.07384 | 0.016723 | 4.970809 |
6,786,048,703,211 | Clinical Application of Noninvasive Molecular Imaging in Cancer Cell Therapy: The First Reporter Gene–Based Imaging Clinical Trial | 274 | 425 | faa5417a35916b26 | 130 | 18 | 23 | 23 | 0 | 0.312988 | 0.218018 | 0.002415 | 0.027499 | 0.300857 | 4.020391 |
|
4,655,745,209,261 | Stem cell therapy to regrow new and healthy cartilage for knee joints | 480 | 360 | 964b6b946b9e6838 | 69 | 12 | 15 | 15 | 0 | 0.359375 | 0.322266 | 0.161987 | 0.038782 | 0.046704 | 4.440662 |
|
3,779,571,624,136 | The MS Alphabet: Hemiparesis, Helper T-cells, HLA and Other ‘H’ Terms | 1,000 | 480 | b6a4ac7b2dba2312 | 69 | 12 | 23 | 25 | 0 | 0.296387 | 0.247192 | 0.005131 | 0.078361 | 0.663759 | 4.910236 |
|
1,374,389,981,952 | Photo of AbbVie and Voyager Therapeutics team up for Alzheimer’s gene therapy | 390 | 220 | 95cf529acd863998 | 77 | 13 | 17 | 20 | 0 | 0.266846 | 0.21167 | 0.015854 | 0.013859 | 0.113457 | 4.665104 |
|
360,777,887,025 | https://www.childrenshospital.org/-/media/Newsroom/NYT-Sickle-Cell-Trial.ashx?h=220&w=320&la=en&hash=6E1149954B1F181204096F3AE7F4A17439C574A9 | Researchers have found no evidence that gene therapy treatment caused leukemia in the patient participating in the BlueBird Bio clinical trials. | 320 | 220 | fb10cf590b90ad2e | 144 | 21 | 23 | 24 | 0 | 0.261475 | 0.214355 | 0.000048 | 0.016626 | 0.054999 | 5.174031 |
7,490,423,494,972 | AveXis Reports on Rett Gene Therapy Program: AVXS-201 | 900 | 420 | 80d2773d3f2bc4c2 | 53 | 9 | 16 | 17 | 4 | 0.243286 | 0.171021 | 0.000171 | 0.002997 | 0.007418 | 5.170033 |
|
2,233,383,352,836 | Gene therapy for optic atrophy | 300 | 278 | 953f493a14b54a6b | 30 | 5 | 7 | 6 | 0 | 0.284912 | 0.253662 | 0.188721 | 0.059871 | 0.575825 | 4.579835 |
|
3,779,571,286,807 | Bluebird Bio Sets $1.8M Price on Gene Therapy for Rare Blood Disease | 1,100 | 733 | d39664c49a24d3db | 68 | 13 | 17 | 17 | 0 | 0.293213 | 0.22876 | 0.001309 | 0.013569 | 0.004127 | 5.408133 |
|
6,262,062,480,559 | Can Stem Cell Therapy Regrow Cartilage? | 300 | 225 | 850cdaf39de46c1c | 39 | 6 | 10 | 10 | 0 | 0.31665 | 0.237183 | 0.00072 | 0.035537 | 0.205198 | 5.230237 |
|
3,685,082,426,472 | https://www.rdm.ox.ac.uk/about/our-divisions/nuffield-division-of-clinical-laboratory-sciences/nuffield-division-of-clinical-laboratory-sciences-research/gene-medicine-group/responsive_image?ratio=r16x9&scale=w760 | We are developing gene therapy for lung conditions, including the genetic disease Cystic Fibrosis (CF). We are also evaluating whether the lung can be used as a ‘protein factory’ to make therapeutic proteins such as antibodies. | 760 | 427 | d4f7c0db00c768cb | 227 | 36 | 46 | 46 | 0 | 0.270996 | 0.206909 | 0.000147 | 0.023204 | 0.00705 | 4.636904 |
6,408,091,966,937 | http://altheadistributor.com/images_ad_wordpress/img_stemcells_02.jpg | laminine is not a stemcell therapy | 650 | 310 | a6e32326da199cdc | 34 | 6 | 10 | 10 | 0 | 0.296143 | 0.238037 | 0.002153 | 0.014052 | 0.39197 | 4.789815 |
816,043,874,970 | T-cell production process diagram | 555 | 285 | 9f07a0e06f3e17c8 | 33 | 5 | 6 | 6 | 0 | 0.301514 | 0.312744 | 0.003967 | 0.011498 | 0.049894 | 4.972815 |
|
369,367,887,036 | disadvantages of stem cell therapy | 1,024 | 768 | c35d547795976288 | 34 | 5 | 6 | 7 | 0 | 0.347168 | 0.284668 | 0.001976 | 0.020016 | 0.247513 | 5.113388 |
|
2,121,714,475,422 | The Regenerative Revolution: Repair, Regenerate, Regrow: Stem Cell Therapy For Your Pet | 313 | 500 | a750d06f9982bf15 | 87 | 12 | 21 | 21 | 1 | 0.392334 | 0.339355 | 0.000437 | 0.007694 | 0.329725 | 4.567517 |
|
2,190,433,915,427 | Cell Therapy in Asia | 999 | 753 | dfc02f0e6c5a7c0a | 20 | 4 | 4 | 4 | 0 | 0.276367 | 0.260742 | 0.001498 | 0.007972 | 0.021057 | 5.169292 |
|
7,181,185,362,203 | t>PD-1/PD-L1</t> interaction blockade and T-cell activation enhancement by SPE components in vitro . (A) Chemical components of SPE. (B) The ability of seven components from SPE to enhance T-cell functional activity was assessed using a PD-1/PD-L1 blockade bioassay. These seven components were used at a concentration of 2 µM. (C, D) A PD-1/PD-L1 blockade bioassay was performed to measure the inhibitory activity of apigenin and cosmosiin. PD-L1 aAPC/CHO-K1 cells were plated and incubated at 37°C for 20 h prior to the addition of PD-1 effector cells and increasing concentrations of apigenin or cosmosiin. (E, F) Competitive ELISA was performed using a PD-1/PD-L1 inhibitor ELISA-binding assay after treatment with the indicated concentrations of (E) apigenin and (F) cosmosiin. Bar graph (mean ± standard error of the mean) statistics were determined with data of three experiments, using one-way ANOVA with Tukey’s post-hoc test; ***P | 708 | 808 | d8c7a5a55aa4a729 | 940 | 165 | 256 | 257 | 0 | 0.303223 | 0.22229 | 0.000731 | 0.01282 | 0.000316 | 3.800317 |
|
5,566,278,226,416 | Depiction of CAR T-cell therapy binding to a myeloma cell | 748 | 450 | 96093f846ca3b68f | 57 | 11 | 14 | 15 | 0 | 0.290283 | 0.227661 | 0.027405 | 0.018179 | 0.8886 | 5.405082 |
|
4,861,903,015,101 | Dr. Robert Niedbalski - Hair Transplant Surgeon - Hair Transplant - hair loss - PRP therapy - Dr. Niedbalski - hair restoration - stem cell therapy | 461 | 405 | b371c63666c69e88 | 147 | 19 | 35 | 41 | 1 | 0.271729 | 0.224609 | 0.00056 | 0.012698 | 0.056735 | 5.18312 |
|
506,806,552,532 | Number of in vivo gene therapy trials per year 2011-2019 | 500 | 400 | ea803d3fc45e99d0 | 56 | 11 | 12 | 12 | 0 | 0.385742 | 0.364014 | 0.003319 | 0.024702 | 0.000743 | 5.406374 |
|
420,907,545,492 | Clinical trials investigate the use of stem cell therapy for treating COVID-19 | 500 | 383 | dc58b1dc98c193a7 | 78 | 13 | 15 | 16 | 1 | 0.251709 | 0.197632 | 0.004963 | 0.25938 | 0.726312 | 4.935683 |
|
7,146,825,743,919 | Flow Cytometry: CD2 Antibody (RPA-2.10) [NBP2-25200] - CD3+ T-Cells isolated from PBMCs stained with anti-CD2 Alexa Fluor 488 (BL1). Image from a verified customer review. | 400 | 370 | e696d86989798758 | 171 | 29 | 62 | 61 | 0 | 0.350098 | 0.310059 | 0.000795 | 0.025759 | 0.000041 | 4.448392 |
|
584,115,668,776 | Chlorinator Pro CP-15 Aqua Rite Replacement Salt Water T-Cell-15 Hayward to 40K | 328 | 218 | bc34c34b3c94de23 | 79 | 15 | 21 | 21 | 0 | 0.271484 | 0.238159 | 0.001945 | 0.020303 | 0.001855 | 4.087737 |
|
8,452,495,653,545 | Novartis’s $90 million Swiss factory to help solve cell therapy bottleneck | 1,280 | 640 | d0b32f6b6385b468 | 74 | 12 | 17 | 17 | 0 | 0.158203 | 0.142944 | 0.002964 | 0.00449 | 0.184577 | 4.995582 |
|
6,674,379,262,284 | Surgery Vs Stem Cell Therapy | 1,536 | 1,028 | c593146b18371e3f | 28 | 5 | 5 | 7 | 0 | 0.280518 | 0.234863 | 0.003952 | 0.182537 | 0.680105 | 5.436047 |
|
7,060,926,378,081 | autologous blood donation and transfusion n. | 720 | 540 | 865e5db09f0cec94 | 44 | 6 | 10 | 10 | 0 | 0.344482 | 0.321289 | 0.003223 | 0.027788 | 0.037523 | 4.056946 |
|
8,366,596,416,921 | Skin-cells-turned-to-heart-cells help unravel genetic underpinnings of cardiac function | 640 | 400 | bd6903d364a5d625 | 87 | 13 | 23 | 21 | 0 | 0.285645 | 0.24231 | 0.000097 | 0.061833 | 0.731993 | 5.469877 |
|
8,701,603,971,329 | New Gene Therapy for Eye Disease | 382 | 203 | d74a0dcc78e74724 | 32 | 6 | 6 | 6 | 0 | 0.311768 | 0.200684 | 0.003057 | 0.013303 | 0.003049 | 3.869502 |
|
7,387,344,183,912 | https://i1.abocdn.com/productimage/v29901358/a3z33u2h6q4c/?w=300&h=200 | Image no. 2 for anti-IL2-Inducible T-Cell Kinase (ITK) antibody (ABIN1109424 | 300 | 200 | a90678f77ae16524 | 76 | 13 | 29 | 29 | 0 | 0.2229 | 0.223267 | 0.000242 | 0.007125 | 0.000377 | 3.872651 |
8,306,467,068,122 | Gene Therapy for Duchenne Muscular Dystrophy | 413 | 232 | fca0235f316c6a66 | 44 | 6 | 11 | 11 | 0 | 0.274658 | 0.223877 | 0.000881 | 0.012466 | 0.109925 | 5.444393 |
|
3,796,751,171,527 | Gene Therapy Sickle Cell | 640 | 723 | a71b3856c52e68da | 24 | 4 | 5 | 5 | 0 | 0.300293 | 0.27002 | 0.007191 | 0.028537 | 0.002321 | 5.38235 |
|
5,677,947,083,665 | https://i1.abocdn.com/productimage/vf1065d22/v0f31w2n8x2x/?w=300&h=200 | Image no. 1 for anti-Transcription Factor 7-Like 2 (T-Cell Specific, HMG-Box) (TCF7L2) (AA 61-90), (N-Term) antibody (ABIN5535025 | 300 | 200 | b366646666666633 | 129 | 23 | 51 | 50 | 0 | 0.326172 | 0.238037 | 0.001803 | 0.009806 | 0.03574 | 3.941676 |
1,623,498,071,797 | Identifying Adventitious Agents in Cell & Gene Therapy Production | 344 | 487 | bf2bd49d528dc0c2 | 65 | 8 | 11 | 11 | 0 | 0.328613 | 0.261719 | 0.001814 | 0.021856 | 0.016206 | 4.366419 |
|
5,222,680,940,654 | Advanced Textbook on Gene Transfer, Gene Therapy and Genetic Pharmacology | 282 | 375 | eac8a537c06c37d4 | 73 | 10 | 14 | 13 | 0 | 0.403076 | 0.36084 | 0.000101 | 0.02999 | 0.227834 | 3.150829 |